| Dr Lirim Krveshi, DO | |
|
112 Hospital Ln Ste 303, Danville, IN 46122-1998 | |
| (317) 718-4000 | |
| (317) 718-4005 |
| Full Name | Dr Lirim Krveshi |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 10 Years |
| Location | 112 Hospital Ln Ste 303, Danville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255759536 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
The "omics" revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. New biomarkers are discovered each day and this rapid development promises excellent growth potential for the biomarker analysis market. However, due to various challenges faced in biomarker validation and assay development, there is a huge lag between the time that a biomarker is discovered in the laboratory and the time it is actually commercialized.
College freshmen under the age of 20 at several colleges in the southeastern U.S. were almost 70 percent more likely to test positive for chlamydia than students between 20 and 24 years of age, according to findings by Adelbert James, PhD, MPH, senior associate in the Department of Gynecology and Obstetrics at Emory University School of Medicine.
Artificial intelligence may significantly improve the accuracy of premature death prediction for patients with chronic disease, compared with standard models.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
uniQure N.V., a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.
› Verified 8 days ago
| Entity Name | Hendricks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
The "omics" revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. New biomarkers are discovered each day and this rapid development promises excellent growth potential for the biomarker analysis market. However, due to various challenges faced in biomarker validation and assay development, there is a huge lag between the time that a biomarker is discovered in the laboratory and the time it is actually commercialized.
College freshmen under the age of 20 at several colleges in the southeastern U.S. were almost 70 percent more likely to test positive for chlamydia than students between 20 and 24 years of age, according to findings by Adelbert James, PhD, MPH, senior associate in the Department of Gynecology and Obstetrics at Emory University School of Medicine.
Artificial intelligence may significantly improve the accuracy of premature death prediction for patients with chronic disease, compared with standard models.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
uniQure N.V., a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lirim Krveshi, DO 112 Hospital Ln, Ste 303, Danville, IN 46122-1998 Ph: (203) 739-8048 | Dr Lirim Krveshi, DO 112 Hospital Ln Ste 303, Danville, IN 46122-1998 Ph: (317) 718-4000 |
News Archive
The "omics" revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. New biomarkers are discovered each day and this rapid development promises excellent growth potential for the biomarker analysis market. However, due to various challenges faced in biomarker validation and assay development, there is a huge lag between the time that a biomarker is discovered in the laboratory and the time it is actually commercialized.
College freshmen under the age of 20 at several colleges in the southeastern U.S. were almost 70 percent more likely to test positive for chlamydia than students between 20 and 24 years of age, according to findings by Adelbert James, PhD, MPH, senior associate in the Department of Gynecology and Obstetrics at Emory University School of Medicine.
Artificial intelligence may significantly improve the accuracy of premature death prediction for patients with chronic disease, compared with standard models.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
uniQure N.V., a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.
› Verified 8 days ago
Dr. Daniela Budiu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ln, Ste 120, Danville, IN 46122 Phone: 317-745-3830 Fax: 317-745-3832 | |
Dr. Frank Paul Troiano, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ln Ste 100, Danville, IN 46122 Phone: 317-745-7310 Fax: 317-745-7320 | |
Bradley P Hamrick, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ln, Suite 115, Danville, IN 46122 Phone: 317-718-4066 | |
Priya P Menon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ln, Suite 205, Danville, IN 46122 Phone: 317-745-7445 Fax: 317-745-7449 | |
Mason F Copeland, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-718-4740 Fax: 317-718-6760 | |
Dr. Angela Toni Corea, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-745-4451 Fax: 317-718-6740 |